304 related articles for article (PubMed ID: 33813611)
1. Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study.
Spinella TC; Stewart SH; Naugler J; Yakovenko I; Barrett SP
Psychopharmacology (Berl); 2021 Jul; 238(7):1965-1977. PubMed ID: 33813611
[TBL] [Abstract][Full Text] [Related]
2. The impact of cannabidiol placebo on responses to an acute stressor: A replication and proof of concept study.
Zhekova RM; Perry RN; Spinella TC; Dockrill K; Stewart SH; Barrett SP
J Psychopharmacol; 2024 Jan; 38(1):116-124. PubMed ID: 38214314
[TBL] [Abstract][Full Text] [Related]
3. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis.
Appiah-Kusi E; Petros N; Wilson R; Colizzi M; Bossong MG; Valmaggia L; Mondelli V; McGuire P; Bhattacharyya S
Psychopharmacology (Berl); 2020 Apr; 237(4):1121-1130. PubMed ID: 31915861
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Cannabidiol Expectancy on Cortisol Responsivity in the Context of Acute Stress: Associations with Biological Sex.
Spinella TC; Burdeyny V; Oprea A; Perrot TS; Barrett SP
Cannabis Cannabinoid Res; 2023 Aug; ():. PubMed ID: 37552817
[No Abstract] [Full Text] [Related]
5. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
Bergamaschi MM; Queiroz RH; Chagas MH; de Oliveira DC; De Martinis BS; Kapczinski F; Quevedo J; Roesler R; Schröder N; Nardi AE; Martín-Santos R; Hallak JE; Zuardi AW; Crippa JA
Neuropsychopharmacology; 2011 May; 36(6):1219-26. PubMed ID: 21307846
[TBL] [Abstract][Full Text] [Related]
7. A naturalistic examination of the perceived effects of cannabis on negative affect.
Cuttler C; Spradlin A; McLaughlin RJ
J Affect Disord; 2018 Aug; 235():198-205. PubMed ID: 29656267
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease.
de Faria SM; de Morais Fabrício D; Tumas V; Castro PC; Ponti MA; Hallak JE; Zuardi AW; Crippa JAS; Chagas MHN
J Psychopharmacol; 2020 Feb; 34(2):189-196. PubMed ID: 31909680
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats.
Resstel LB; Tavares RF; Lisboa SF; Joca SR; Corrêa FM; Guimarães FS
Br J Pharmacol; 2009 Jan; 156(1):181-8. PubMed ID: 19133999
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test.
Linares IM; Zuardi AW; Pereira LC; Queiroz RH; Mechoulam R; Guimarães FS; Crippa JA
Braz J Psychiatry; 2019; 41(1):9-14. PubMed ID: 30328956
[TBL] [Abstract][Full Text] [Related]
11. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder.
Bolsoni LM; Crippa JAS; Hallak JEC; Guimarães FS; Zuardi AW
Psychopharmacology (Berl); 2022 May; 239(5):1499-1507. PubMed ID: 35029706
[TBL] [Abstract][Full Text] [Related]
12. The effects of a brand-specific, hemp-derived cannabidiol product on physiological, biochemical, and psychometric outcomes in healthy adults: a double-blind, randomized clinical trial.
Mastrofini GF; McFadden BA; Chandler AJ; Lints BS; Cintineo HP; Rhoades ND; Vincenty CS; Stray-Gundersen SO; Lane AD; Arent SM
J Int Soc Sports Nutr; 2024 Dec; 21(1):2370430. PubMed ID: 38904150
[TBL] [Abstract][Full Text] [Related]
13. The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study.
Bloomfield MAP; Yamamori Y; Hindocha C; Jones APM; Yim JLL; Walker HR; Statton B; Wall MB; Lees RH; Howes OD; Curran VH; Roiser JP; Freeman TP
Psychopharmacology (Berl); 2022 May; 239(5):1539-1549. PubMed ID: 35445839
[TBL] [Abstract][Full Text] [Related]
14. Effects of cannabidiol (CBD) on regional cerebral blood flow.
Crippa JA; Zuardi AW; Garrido GE; Wichert-Ana L; Guarnieri R; Ferrari L; Azevedo-Marques PM; Hallak JE; McGuire PK; Filho Busatto G
Neuropsychopharmacology; 2004 Feb; 29(2):417-26. PubMed ID: 14583744
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.
Martin-Santos R; Crippa JA; Batalla A; Bhattacharyya S; Atakan Z; Borgwardt S; Allen P; Seal M; Langohr K; Farré M; Zuardi AW; McGuire PK
Curr Pharm Des; 2012; 18(32):4966-79. PubMed ID: 22716148
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.
Hurd YL; Spriggs S; Alishayev J; Winkel G; Gurgov K; Kudrich C; Oprescu AM; Salsitz E
Am J Psychiatry; 2019 Nov; 176(11):911-922. PubMed ID: 31109198
[TBL] [Abstract][Full Text] [Related]
17. A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood.
Manning B; Hayley AC; Catchlove S; Stough C; Downey LA
Eur Neuropsychopharmacol; 2024 May; 82():35-43. PubMed ID: 38490083
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial.
Gundugurti PR; Banda N; Yadlapalli SSR; Narala A; Thatikonda R; Kocherlakota C; Kothapalli KS
Asian J Psychiatr; 2024 Jul; 97():104073. PubMed ID: 38797087
[TBL] [Abstract][Full Text] [Related]
19. The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial.
Gournay LR; Ferretti ML; Bilsky S; Vance E; Nguyen AM; Mann E; Williams P; Leen-Feldner EW
Psychopharmacology (Berl); 2023 Oct; 240(10):2147-2161. PubMed ID: 37552290
[TBL] [Abstract][Full Text] [Related]
20. A Double-Blind, Randomized, Placebo-Controlled Test of the Effects of Cannabidiol on Experiences of Test Anxiety Among College Students.
Stanley TB; Ferretti ML; Bonn-Miller MO; Irons JG
Cannabis Cannabinoid Res; 2023 Dec; 8(6):1090-1099. PubMed ID: 35861792
[No Abstract] [Full Text] [Related]
[Next] [New Search]
